APA (7th ed.) Citation

Li, L., Chen, L., Yan, L., Guo, Y., Li, F., Fan, M., . . . Feng, M. (2023). Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients. Radiation Oncology, 18(1), 1. https://doi.org/10.1186/s13014-023-02310-8

Chicago Style (17th ed.) Citation

Li, Lu, et al. "Initial Analysis of the Synergy of Programmed Cell Death-1 (PD-1) Inhibitor and Concurrent Chemoradiotherapy Treatment for Recurrent/metastatic Head and Neck Squamous Cell Carcinoma Patients." Radiation Oncology 18, no. 1 (2023): 1. https://doi.org/10.1186/s13014-023-02310-8.

MLA (9th ed.) Citation

Li, Lu, et al. "Initial Analysis of the Synergy of Programmed Cell Death-1 (PD-1) Inhibitor and Concurrent Chemoradiotherapy Treatment for Recurrent/metastatic Head and Neck Squamous Cell Carcinoma Patients." Radiation Oncology, vol. 18, no. 1, 2023, p. 1, https://doi.org/10.1186/s13014-023-02310-8.